JP2002513813A - ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法 - Google Patents
ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法Info
- Publication number
- JP2002513813A JP2002513813A JP2000547238A JP2000547238A JP2002513813A JP 2002513813 A JP2002513813 A JP 2002513813A JP 2000547238 A JP2000547238 A JP 2000547238A JP 2000547238 A JP2000547238 A JP 2000547238A JP 2002513813 A JP2002513813 A JP 2002513813A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- hpv
- preparation
- helicase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8394298P | 1998-05-01 | 1998-05-01 | |
| US60/083,942 | 1998-05-01 | ||
| PCT/CA1999/000389 WO1999057283A1 (en) | 1998-05-01 | 1999-04-28 | Preparation of human papillomavirus e1 having helicase activity and method therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002513813A true JP2002513813A (ja) | 2002-05-14 |
| JP2002513813A5 JP2002513813A5 (cg-RX-API-DMAC7.html) | 2006-06-22 |
Family
ID=22181652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000547238A Pending JP2002513813A (ja) | 1998-05-01 | 1999-04-28 | ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6306580B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1073750A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002513813A (cg-RX-API-DMAC7.html) |
| AU (1) | AU767903B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2326402A1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0101396A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL139270A0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ508519A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999057283A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL140524A0 (en) * | 1998-07-21 | 2002-02-10 | Boehringer Ingelheim Ca Ltd | Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| HUP0201512A3 (en) | 1999-06-17 | 2010-01-28 | Boehringer Ingelheim Ca Ltd | New atpase assay |
| GB0017990D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Papilloma virus sequences |
| US7167801B2 (en) | 2001-07-12 | 2007-01-23 | Boehringer Ingelheim (Canada) Ltd. | Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates |
| WO2003068940A2 (en) * | 2002-02-14 | 2003-08-21 | Curagen Corporation | Complexes and methods of using same |
| USD1070308S1 (en) * | 2023-07-13 | 2025-04-15 | Wolverine Outdoors, Inc. | Footwear sole |
| USD1067593S1 (en) * | 2023-07-13 | 2025-03-25 | Wolverine Outdoors, Inc. | Footwear sole |
| USD1067594S1 (en) * | 2023-07-13 | 2025-03-25 | Wolverine Outdoors, Inc. | Footwear sole |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464936A (en) * | 1990-12-21 | 1995-11-07 | Cetus Oncology Corporation | Compositions for identification of papillomavirus replication inhibitors |
-
1999
- 1999-04-28 EP EP99917722A patent/EP1073750A1/en not_active Withdrawn
- 1999-04-28 JP JP2000547238A patent/JP2002513813A/ja active Pending
- 1999-04-28 NZ NZ508519A patent/NZ508519A/en unknown
- 1999-04-28 HU HU0101396A patent/HUP0101396A3/hu unknown
- 1999-04-28 WO PCT/CA1999/000389 patent/WO1999057283A1/en not_active Ceased
- 1999-04-28 IL IL13927099A patent/IL139270A0/xx unknown
- 1999-04-28 CA CA002326402A patent/CA2326402A1/en not_active Abandoned
- 1999-04-28 US US09/300,909 patent/US6306580B1/en not_active Expired - Lifetime
- 1999-04-28 AU AU35923/99A patent/AU767903B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2326402A1 (en) | 1999-11-11 |
| EP1073750A1 (en) | 2001-02-07 |
| HUP0101396A2 (hu) | 2001-08-28 |
| AU3592399A (en) | 1999-11-23 |
| AU767903B2 (en) | 2003-11-27 |
| US6306580B1 (en) | 2001-10-23 |
| WO1999057283A1 (en) | 1999-11-11 |
| IL139270A0 (en) | 2001-11-25 |
| NZ508519A (en) | 2003-12-19 |
| HUP0101396A3 (en) | 2006-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hughes et al. | E1 protein of human papillomavirus is a DNA helicase/ATPase | |
| Bierle et al. | Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1 | |
| Dixon et al. | The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificity | |
| Black et al. | Characterization of the interactions among vaccinia virus transcription factors G2R, A18R, and H5R | |
| PL184022B1 (pl) | Izolowany kwas nukleinowy kodujący białka ludzkiego wirusa brodawczaków typu 18, wektor obejmujący ten kwas nukleinowy oraz sposób wyrażania białka ludzkiego wirusa brodawczaków typu 18 w komórce gospodarza przy użyciu tego wektora | |
| WO2002070739A2 (en) | Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv | |
| US6306580B1 (en) | Preparation of human papillomavirus E1 having helicase activity and method therefor | |
| Lu et al. | Identification of a novel shrimp protein phosphatase and its association with latencey‐related ORF427 of white spot syndrome virus | |
| US5821048A (en) | Methods, kits, and compositions for diagnosing papillomavirus infection | |
| US6300067B1 (en) | TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth | |
| Castellino et al. | trans-Dominant and non-trans-dominant mutant simian virus 40 large T antigens show distinct responses to ATP | |
| US6518014B1 (en) | Hepadnavirus cores | |
| US6916622B2 (en) | Regions of papilloma virus E1 helicase involved in E1 oligomerization | |
| MXPA00010584A (en) | Preparation of human papillomavirus e1 having helicase activity and method therefor | |
| Schildgen et al. | Temperature-sensitive origin-binding protein as a tool for investigations of herpes simplex virus activities in vivo | |
| US9783584B2 (en) | Methods and compositions for expressing functional class XIV myosin | |
| AU2004200590A1 (en) | Regions of papilloma virus E1 helicase involved in E1 oligomerization | |
| JP2002516096A (ja) | 転写調節に使用するための、CREB結合タンパク質および関連するp300由来のポリペプチド | |
| Ebrahimi et al. | Genetic polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta1 (GSTT1) and bronchial asthma susceptibility in Ukrainian population | |
| AU2002244566B2 (en) | Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV | |
| Larson et al. | Functional Characterization of a Purified, Recombinant NF-κB/IκB Complex | |
| Taylor | The role of DNA damage proteins and signaling pathways in the regulatory functions of the Human Papillomavirus 16 E2 protein | |
| JP2004173691A (ja) | 変異型エストロゲンレセプターαおよびその遺伝子 | |
| WO2001097847A1 (en) | Icp27-binding polynucleotides | |
| KR19990086165A (ko) | Cdk4 의 저해제인 p16의 카복시말단이 절단된 결손형cδp16 단백질, 그의 유전자 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060428 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060428 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090216 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090806 |